{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:52:40Z","timestamp":1768207960281,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jpsychires.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T02:51:05Z","timestamp":1602816665000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-2236","authenticated-orcid":false,"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Okuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2020.10.009_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.10.009_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1754-4505.2002.tb01166.x","article-title":"A comparison of perceived injection pain with and without anesthetic between elderly and young female subjects","volume":"22","author":"Carr","year":"2002","journal-title":"Spec. Care Dent."},{"issue":"10128","key":"10.1016\/j.jpsychires.2020.10.009_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YCO.0000000000000243","article-title":"Issues related to sex differences in antipsychotic treatment","volume":"29","author":"Crawford","year":"2016","journal-title":"Curr. Opin. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr. Clin. Trials"},{"issue":"10159","key":"10.1016\/j.jpsychires.2020.10.009_bib6","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib7","series-title":"Manual for the ECDEU Assessment Battery","author":"Guy","year":"1970"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YCO.0000000000000160","article-title":"Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance","volume":"28","author":"Haddad","year":"2015","journal-title":"Curr. Opin. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2020.10.009_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.euroneuro.2014.06.015","article-title":"Checking the plausibility of psychiatrists arguments for not prescribing depot medication","volume":"24","author":"Hamann","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib10","author":"Higgins"},{"issue":"10202","key":"10.1016\/j.jpsychires.2020.10.009_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib12","first-page":"1199","article-title":"Comparison study between risperidone long-acting injectable and risperidone tablets in patients with schizophrenia","volume":"12","author":"Kamijima","year":"2009","journal-title":"Jpn. J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2020.10.009_bib13","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.IN18031AH1C","article-title":"Optimizing treatment choices to improve adherence and outcomes in schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.10.009_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2020.2076","article-title":"Effect of long-acting injectable Antipsychotics vs usual care on time to first hospitalization in early-phase schizophrenia: a randomized clinical trial","author":"Kane","year":"2020","journal-title":"JAMA Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2020.10.009_bib15","first-page":"15","article-title":"A double blind comparative study on the efficacy and safety of fluphenazine decanoate (SQ10, 733) and oral haloperidol in the treatment of schizophrenic patients","volume":"19","author":"Kaneno","year":"1991","journal-title":"Rinsho hyoka"},{"issue":"2","key":"10.1016\/j.jpsychires.2020.10.009_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.jpsychires.2020.10.009_bib17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/schbul\/sbw043","article-title":"Mortality risk associated with long-acting injectable Antipsychotics: a systematic review and meta-analyses of randomized controlled trials","volume":"42","author":"Kishi","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/schbul\/sbx090","article-title":"Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies","volume":"44","author":"Kishimoto","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.jpsychires.2020.10.009_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.13r08440","article-title":"Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies","volume":"74","author":"Kishimoto","year":"2013","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2020.10.009_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/schbul\/sbs150","article-title":"Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials","volume":"40","author":"Kishimoto","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2020.10.009_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.schres.2007.09.006","article-title":"Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI","volume":"98","author":"Levine","year":"2008","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.jpsychires.2020.10.009_bib22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2020.10.009_bib23","first-page":"1847","article-title":"Comparison of the defined daily dose and chlorpromazine equivalent methods in antipsychotic drug utilization in six asian countries","volume":"8","author":"Lin","year":"2018","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib24","article-title":"Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics","volume":"9","author":"Mace","year":"2019","journal-title":"Ther. Adv. Psychopharmacol. Ther. Adv. Psychopharmacol."},{"issue":"15","key":"10.1016\/j.jpsychires.2020.10.009_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2165\/00002512-200320150-00003","article-title":"Long-acting injectable antipsychotics in the elderly: guidelines for effective use","volume":"20","author":"Masand","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib26","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib27","first-page":"10","article-title":"Comparative efficacy, tolerability and influence on social functioning of prolonged risperidone (Consta) and olanzapine in longterm treatment of schizophrenia and schizoaffective disorder [In Russian] Sovrem","volume":"2","author":"Mosolov","year":"2008"},{"key":"10.1016\/j.jpsychires.2020.10.009_bib28","first-page":"983","article-title":"A double blind controlled study on the efficacy and safety of long-acting haloperidol (haloperidol decanoate) and oral haloperidol in the treatment of schizophrenic patients","volume":"7","author":"Okuma","year":"1985","journal-title":"Jpn. J. Neuropsychopharmacol."},{"issue":"7610","key":"10.1016\/j.jpsychires.2020.10.009_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/bmj.39227.616447.BE","article-title":"Schizophrenia","volume":"335","author":"Picchioni","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.pain.2011.11.025","article-title":"A systematic literature review of 10 years of research on sex\/gender and experimental pain perception - part 1: are there really differences between women and men?","volume":"153","author":"Racine","year":"2012","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jpsychires.2020.10.009_bib31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1176\/appi.ajp.161.8.1324","article-title":"Gender differences in the prescribing of antipsychotic drugs","volume":"161","author":"Seeman","year":"2004","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2020.10.009_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1078390309350918","article-title":"Schizophrenia: women bear a disproportionate toll of antipsychotic side effects","volume":"16","author":"Seeman","year":"2010","journal-title":"J. Am. Psychiatr. Nurses Assoc."},{"issue":"3","key":"10.1016\/j.jpsychires.2020.10.009_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/15748847113089990051","article-title":"The pharmacokinetics of long-acting antipsychotic medications","volume":"9","author":"Spanarello","year":"2014","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2020.10.009_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2017.12.010","article-title":"Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia","volume":"197","author":"Taipale","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2020.10.009_bib35","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1192\/bjp.195.52.s13","article-title":"Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review","volume":"52","author":"Taylor","year":"2009","journal-title":"Br. J. Psychiatr. Suppl."},{"issue":"7","key":"10.1016\/j.jpsychires.2020.10.009_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.10.009_bib37","unstructured":"WHO, Defined daily dose (DDD). https:\/\/www.who.int\/medicines\/regulation\/medicines-safety\/toolkit_ddd\/en\/."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620310128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620310128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:18:03Z","timestamp":1758367083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395620310128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"alternative-id":["S0022395620310128"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.10.009","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}